INKT vs AMGN: Which Stock is Better?
Side-by-side comparison of Mink Therapeutics Inc and Amgen Inc in 2026
INKT
Mink Therapeutics Inc
$12.94
AMGN
Amgen Inc
$348.22
Key Metrics Comparison
| Metric | INKT | AMGN | Winner |
|---|---|---|---|
| Market Cap | $67.09M | $189.19B | AMGN |
| P/E Ratio | N/A | 24.70 | AMGN |
| EPS (TTM) | $N/A | $14.21 | AMGN |
| Revenue Growth | 0.0% | 0.1% | AMGN |
| Gross Margin | 0.0% | 70.8% | AMGN |
Analyze INKT
Full quant analysis
Analyze AMGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is INKT or AMGN a better investment?
Comparing INKT and AMGN: Mink Therapeutics Inc has a market cap of $67.09M while Amgen Inc has $189.19B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between INKT and AMGN?
INKT (Mink Therapeutics Inc) and AMGN (Amgen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: INKT or AMGN?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: INKT or AMGN?
AMGN has higher revenue growth at 0.1% vs 0.0% for INKT.
Which company is more profitable: INKT or AMGN?
Amgen Inc (AMGN) has higher gross margins at 70.8% compared to 0.0% for INKT.
Which is the larger company: INKT or AMGN?
Amgen Inc (AMGN) is larger with a market cap of $189.19B compared to $67.09M for INKT.
Should I buy INKT or AMGN in 2026?
Both INKT and AMGN have investment merit. INKT trades at $12.94 while AMGN trades at $348.22. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between INKT and AMGN stock?
Key differences: Market Cap ($67.09M vs $189.19B), P/E Ratio (N/A vs 24.7x), Revenue Growth (0.0% vs 0.1%), Gross Margin (0.0% vs 70.8%).